Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M

June 14, 2022 01:24 PM AEST | By Sonal Goyal
 Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M
Image source: © Andreyyalansky19 | Megapixl.com

Highlights

  • Pro Medicus has signed a renewal contract with Sutter Health for another seven years.
  • A renewal contract is also inked with Wellspan Health for further five years.
  • The share price of Pro Medicus has gained by over 650% in last 5 years.

Healthcare informatics company, Pro Medicus Limited (ASX:PME) made headlines on Tuesday (14 June 2022) after it announced that it has signed two contract renewals with a minimum of AU$47 million.

Despite this positive announcement, the shares of Pro Medicus were trading down on the ASX. The share price was quoted at AU$38.605, 6.706% lower at 12:30 PM AEST. 

The shares have shed off more than 7% in last five trading days and more than 6% in one month. But if we look at the performance in last five years, Pro Medicus shares have gained almost 650%.

Meanwhile, today, Pro Medicus’ performance was aligned with the broader market, ASX200, which dropped by 313.70 points at around 12:30 PM. Moreover, the benchmark index, ASX200 Health care (XHJ) which was down by 4.48% to 38,333.

Details of the AU$47M renewal contracts

According to the ASX-announcement, Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus, has signed a renewal contract with Sutter Health for seven years. Sutter Health is a large IDN (integrated delivery network) based in California.

Another contract with Wellspan Health is renewed for five years. It is an integrated health system which is based in Pennsylvania.

Through ASX-announcement, Pro Medicus management informed that both contracts are transaction-based, with potential upside. In addition, the arrangements are negotiated at a higher fee per transaction than the original contracts.

On the development, the CEO of the company, Sam Hupert said:


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.